Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001108205-25-000107
Filing Date
2025-11-06
Accepted
2025-11-06 16:09:06
Documents
63
Period of Report
2025-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q cris-20250930.htm   iXBRL 10-Q 906436
2 EX-31.1 cris-9302025x10qexx311.htm EX-31.1 10640
3 EX-31.2 cris-9302025x10qexx312.htm EX-31.2 10594
4 EX-32.1 cris-9302025x10qexx321.htm EX-32.1 4686
5 EX-32.2 cris-9302025x10qexx322.htm EX-32.2 4649
  Complete submission text file 0001108205-25-000107.txt   5118893

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cris-20250930.xsd EX-101.SCH 42679
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cris-20250930_cal.xml EX-101.CAL 39838
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cris-20250930_def.xml EX-101.DEF 160387
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cris-20250930_lab.xml EX-101.LAB 578589
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cris-20250930_pre.xml EX-101.PRE 364940
66 EXTRACTED XBRL INSTANCE DOCUMENT cris-20250930_htm.xml XML 575790
Mailing Address 128 SPRING STREET BUILDING C, SUITE 500 LEXINGTON MA 02421
Business Address 128 SPRING STREET BUILDING C, SUITE 500 LEXINGTON MA 02421 617-503-6500
CURIS INC (Filer) CIK: 0001108205 (see all company filings)

EIN.: 043505116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30347 | Film No.: 251458300
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)